Hepatitis C Virus Infection and Kidney Transplantation A Review for Clinicians

被引：0
作者：
Einollahi, Behzad [1 ]
Alavian, Seyed-Moayed [2 ]
机构：
[1] Baqiyatallah Univ Med Sci, Nephrol & Urol Res Ctr, Tehran, Iran
[2] Baqiyatallah Univ Med Sci, Baqiyatallah Res Ctr Gastroenterol & Liver Dis, Tehran, Iran
来源：
IRANIAN JOURNAL OF KIDNEY DISEASES | 2010年 / 4卷 / 01期
关键词：
hepatitis C virus; kidney transplant recipients; survival analysis; RENAL-ALLOGRAFT RECIPIENTS; POSTTRANSPLANTATION DIABETES-MELLITUS; RECOMBINANT INTERFERON-ALPHA; HEMODIALYSIS-PATIENTS; ANTIVIRAL THERAPY; VIRAL-HEPATITIS; HCV INFECTION; DIALYSIS PATIENTS; LIVER HISTOLOGY; ANTI-HCV;
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Hepatitis C virus (HCV) infection is frequent among kidney transplant recipients, and it is currently the major cause of chronic liver disease following kidney transplantation. The presence of HCV infection has been found to negatively affect the morbidity and mortality rates in patients on dialysis, as well; it seems that kidney transplantation is a reasonable treatment option after a careful pretransplant evaluation. Nevertheless, there are several questions about the indications of kidney transplantation, pretransplant evaluation, transplantation from HCV-infected donors, patient and graft survival rates, and kidney diseases associated with hepatitis C virus after kidney transplantation. This review deals with the most current information on pretransplant and posttransplant evaluations, complications, treatment, and prognosis of HCV-infected kidney transplant recipients. IJKD 2010;4:1-8 www.ijkd.org
引用
收藏
页码：1 / 8
页数：8
相关论文
共 75 条
[1]  
Alavian SM, 2007, HEPAT MON, V7, P153
[2]  
Alavian Seyed-Moayed, 2008, Iran J Kidney Dis, V2, P110
[3]   A shield against a monster: Hepatitis C in hemodialysis patients [J].
Alavian, Seyed-Moayed .
WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (06) :641-646
[4]  
ALAVIAN SM, 2004, HEPAT MON, V4, P2
[5]   Influence of antiviral therapy in hepatitis C virus-associated cryoglobulinemic MPGN [J].
Alric, L ;
Plaisier, E ;
Théault, S ;
Péron, JM ;
Rostaing, L ;
Pourrat, J ;
Ronco, P ;
Piette, JC ;
Cacoub, P .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 43 (04) :617-623
[6]   Renal disease associated with hepatitis C infection after kidney and liver transplantation [J].
Baid, S ;
Cosimi, AB ;
Tolkoff-Rubin, N ;
Colvin, RB ;
Williams, WW ;
Pascual, M .
TRANSPLANTATION, 2000, 70 (02) :255-261
[7]   Acute humoral rejection in hepatitis C-infected transplant recipients receiving antiviral therapy [J].
Baid, S ;
Tolkoff-Rubin, N ;
Saidman, S ;
Chung, R ;
Williams, WW ;
Auchincloss, H ;
Colvin, RB ;
Delmonico, FL ;
Cosimi, AB ;
Pascual, M .
AMERICAN JOURNAL OF TRANSPLANTATION, 2003, 3 (01) :74-78
[8]   Association of hepatitis C with posttransplant diabetes in renal transplant patients on tacrolimus [J].
Bloom, RD ;
Rao, V ;
Weng, F ;
Grossman, RA ;
Cohen, D ;
Mange, KC .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (05) :1374-1380
[9]   Epidemiological aspects of hepatitis C virus infection among renal transplant recipients in Central Brazil [J].
Botelho, Silvia M. ;
Ferreira, Renata C. ;
Reis, Nadia R. S. ;
Kozlowski, Aline G. ;
Carneiro, Megmar A. S. ;
Teles, Sheila A. ;
Yoshida, Clara F. T. ;
Martins, Regina M. B. .
MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2008, 103 (05) :472-476
[10]   CHRONIC HEPATITIS-C AFTER RENAL-TRANSPLANTATION - TREATMENT WITH ALPHA-INTERFERON [J].
CHAN, TM ;
LOK, ASF ;
CHENG, IKP ;
NG, IOL .
TRANSPLANTATION, 1993, 56 (05) :1095-1098
12345678